Firebrick Pharma (ASX:FRE) Total Payout Ratio : 0.92 (As of Mar. 27, 2025)

View and export this data going back to 2022. Start your Free Trial

What is Firebrick Pharma Total Payout Ratio?

Total Payout Ratio is the percent a company has paid to its shareholders through net repurchase of shares and dividends based on its Net Income.

Firebrick Pharma's current Total Payout Ratio is 0.92.

Firebrick Pharma Total Payout Ratio Historical Data

The historical data trend for Firebrick Pharma's Total Payout Ratio can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

Firebrick Pharma Total Payout Ratio Chart

Firebrick Pharma Annual Data

Trend

Jun21

Jun22

Jun23

Jun24

Total Payout Ratio

2.69

0.15

0.69

Firebrick Pharma Semi-Annual Data
	Jun21	Jun22	Dec22	Jun23	Dec23	Jun24	Dec24
Total Payout Ratio	Get a 7-Day Free Trial			-	0.27	0.01	2.90	0.54

Competitive Comparison of Firebrick Pharma's Total Payout Ratio

For the Drug Manufacturers - General subindustry, Firebrick Pharma's Total Payout Ratio, along with its competitors' market caps and Total Payout Ratio data, can be viewed below:

* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.

Firebrick Pharma's Total Payout Ratio Distribution in the Drug Manufacturers Industry

For the Drug Manufacturers industry and Healthcare sector, Firebrick Pharma's Total Payout Ratio distribution charts can be found below:

* The bar in red indicates where Firebrick Pharma's Total Payout Ratio falls into.

Save Embed

;

Save Embed

;

Firebrick Pharma Total Payout Ratio Calculation

Total Payout Ratio is a measurement showing the proportion of earnings a company pays shareholders in the form of dividends and net stock repurchases.

Firebrick Pharma's Total Payout Ratio for the fiscal year that ended in Jun. 2024 is calculated as

Total Payout Ratio	=	- (Repurchase of Stock	+	Issuance of Stock	+	Cash Flow for Dividends)	/	Net Income
	=	- (-0.005	+	0.821	+	0)	/	-1.176
	=	0.69

Firebrick Pharma's Total Payout Ratio for the quarter that ended in Dec. 2024 is calculated as

Total Payout Ratio	=	- (Repurchase of Stock	+	Issuance of Stock	+	Cash Flow for Dividends)	/	Net Income
	=	- (-0.02	+	0.797	+	0)	/	-1.446
	=	0.54

Firebrick Pharma Total Payout Ratio Related Terms

Thank you for viewing the detailed overview of Firebrick Pharma's Total Payout Ratio provided by GuruFocus.com. Please click on the following links to see related term pages.

Firebrick Pharma Business Description

Industry

GURUFOCUS.COM » STOCK LIST » Healthcare » Drug Manufacturers » Firebrick Pharma Ltd (ASX:FRE) » Definitions » Total Payout Ratio

Comparable Companies

Traded in Other Exchanges

N/A

Address

440 Collins Street, Level 10, Melbourne, VIC, AUS, 3000

Website

https://www.firebrickpharma.com

Firebrick Pharma Ltd is an Australian pharmaceutical developer. It is engaged in the development and commercialization of povidone-iodine (PVP-I) products under the Nasodine brand. Its Nasodine Nasal Spray which is in the commercialization phase, is a broad-spectrum anti-viral spray, designed to be an effective treatment and prevention of respiratory viral infections such as the common cold. In parallel, the company is also engaged in the development of the follow-on Nasodine brand products.

Firebrick Pharma Headlines

No Headlines